Results 191 to 200 of about 205,027 (361)

Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration

open access: yesScience, 2005
J. Haines   +13 more
semanticscholar   +1 more source

Characterization of retinal pigment epithelium layer in healthy and diseased retinas with high‐resolution adaptive optics transscleral flood illumination imaging

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose The retinal pigment epithelium (RPE) is critical in the pathophysiology of retinal diseases, such as age‐related macular degeneration. Adaptive optics transscleral flood illumination (AO‐TFI) offers rapid, detailed morphometric characterization of the RPE layer.
Leila Sara Eppenberger   +8 more
wiley   +1 more source

Pegaptanib for neovascular age-related macular degeneration.

open access: yesNew England Journal of Medicine, 2004
E. Gragoudas   +4 more
semanticscholar   +1 more source

Incidence, risk factors, and outcomes of numerical hypotony and choroidal effusion following PRESERFLO MicroShunt implantation

open access: yesActa Ophthalmologica, EarlyView.
Abstract Purpose To evaluate the incidence, outcomes, and risk factors of numerical hypotony (NH) and choroidal effusion (CE) following standalone PRESERFLO MicroShunt (PMS) implantation. Methods Primary open‐angle glaucoma (POAG) and pseudoexfoliative glaucoma (PXG) patients with uni‐ or bilateral surgery at a tertiary university hospital were ...
Emil Nasyrov   +5 more
wiley   +1 more source

The physiological and pathological effects of sphingolipid metabolism and signaling in the central nervous system

open access: yesBrain Pathology, EarlyView.
Sphingolipids are vital components of cell membranes. Metabolic disruptions of sphingolipids, including ceramide and sphingosine‐1‐phosphate, are linked to neurological disorders. This article summarizes the classification, structure, and metabolic processes of sphingolipids, and the physiological and pathological effects of sphingolipid metabolism and
Tian Li   +7 more
wiley   +1 more source

Review of gene therapies for age-related macular degeneration

open access: yesEye, 2022
A. Khanani   +8 more
semanticscholar   +1 more source

Proposal of a Simpler Eye‐Level Risk Model Incorporating Reticular Pseudodrusen for the Clinical Prediction of Late Age‐Related Macular Degeneration

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background The updated simplified AREDS risk model predicts progression to late age‐related macular degeneration (AMD) by person, describing up to nine observations across both eyes and 10 annual risk scores (0–4, with/without reticular pseudodrusen [RPD]).
Matt Trinh   +8 more
wiley   +1 more source

What’s new in age-related macular degeneration?

open access: yesCommunity Eye Health Journal, 2006
Introduction Age-related macular degeneration (AMD) was regarded as unimportant in global blindness, of relevance only to the minority of the world’s population that live in wealthy countries. However, increasing life expectancy, particularly in Asia,
David Yorston
doaj  

Home - About - Disclaimer - Privacy